Market Brief

The articles are produced in Chinese only.

Author

許偉龍先生(Anthony Hui)
高級交易員

現任職輝立高級交易員,對投資股票經驗豐富。本人樂意為客戶提供投資分析及買賣策略。歡迎各位來電交流心得。
Phone:
36533066

維他奶國際集團有限公司 (345)

Friday, October 28, 2022 Views7110

維他奶國際集團有限公司 (00345.HK)

 

 

 

業務概要: 為香港主要之非酒精類飲品生產商兼分銷商,產品以「維他奶」及「維他」兩個牌子出售。

 

基本資料 :

現價: $12.04

市值: 128.92億

市盈率: N/A

 

52週高/低: $19/ $8.91

10天/50天/100天平均價 : $10.30/ $10.88/ $11.76

 

業務回顧:

截至2022年3月31日止的全年業績,維他奶國際公布,全年盈轉虧蝕1.59億元,上年同期賺5.48億元;每股虧損14.9仙 。年內收入達65.01億元,按年跌13.5%。經營虧損為2.13億元,對比上年錄得溢利8.43億元。主要受中國內地銷售疲弱及政府補貼減少所影響。毛利率由 53%下跌至47%

 

 

評論:

第一,維他奶股價見近52週低位後出現不錯的反彈

11/10 (52週低位)至昨天(27/10)維他奶股價由$8.91升至$12.04, 反彈幅度達35.13%。即使在本週一(24/10)大巿下跌過千點, 維他奶股價仍升$0.52 (+5.19%)。並連續多日錄得淨買入。相信股價已見底, 股價走勢呈出現區域突破。

第二,隨著消費者愈來愈注重健康的飲食習慣,其以植物為主的蛋白質飲料業務仍有增長空間。

 

第三,維他奶國際26/10 收市後發盈喜,預料截至今年9月底止中期將錄得純利介乎1.4億至1.5億元,,對比去年同期的純利3,280.4萬元大幅上升, 相信公司將會恢復派息。

 

第四,鑑於較高的原材料成本,公司將在部分市場調高價格,並將繼續選擇性提價,並採取嚴格的內部成本控制措施以保障利潤率。

 

 

 

買賣策略
買入價: $10.88

目標價: $13.88

止蝕價: $9.79

 

資料來源: 阿斯達克財經網,2022年年度業績公告,新浪財經

 

註:本人許偉龍為證監會持牌人士。截至本評論文章發表日止,本人及/或其有聯繫者並無持有全部提及之証券的所有相關財務權益。

This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on http://www.phillip.com.hk. Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email : businessenquiry@phillip.com.hk

Enquiry & Support
Branches
The Complaint Procedures
About Us
Phillip Securities Group
Join Us
Phillip Network
Phillip Post
Phillip Channel
Latest Promotion
E-Check
Login
Investor Notes
Free Subscribe
Contact Us